Send the following on WhatsApp
Continue to ChatBRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE - https://avesis.erciyes.edu.tr/publication/details/aecc8006-ea95-455a-bb88-aad2933eeac1/brentuximab-vedotin-consolidation-therapy-after-autologous-stem-cell-transplantation-in-patients-with-high-risk-hodgkinxxs-lymphoma-multi-center-real-life-experience